TY - JOUR
T1 - Long-term outcomes following percutaneous coronary intervention to an unprotected left main coronary artery in cardiogenic shock
AU - Yeoh, Julian
AU - Andrianopoulos, Nick
AU - Reid, Christopher M.
AU - Yudi, Matias B.
AU - Hamilton, Garry
AU - Freeman, Melaine
AU - Noaman, Samer
AU - Oqueli, Ernesto
AU - Picardo, Sandra
AU - Brennan, Angela
AU - Chan, William
AU - Stub, Dion
AU - Duffy, Stephen
AU - Farouque, Omar
AU - Ajani, Andrew
AU - Clark, David J.
AU - on behalf of the Melbourne Interventional Group (MIG)
N1 - Funding Information:
MIG Data Management Centre, CCRE, Monash University:, Professor Chris Reid, Dr. Nick Andrianopoulos, Ms. Angela Brennan, Dr. Diem Dinh. MIG Steering Committee:, Professor Chris Reid, Associate Professor Andrew Ajani, Professor Stephen Duffy, Associate Professor David Clark, Dr. Melanie Freeman, Dr. Chin Hiew, Associate Prof Ernesto Oqueli, Ms. Angela Brennan. The following investigators, data managers and institutions participated in the MIG Database:, Alfred Hospital: SJ Duffy, D Stub, JA Shaw, A Walton, A Dart, A Broughton, C Keighley, C Hengel, KH Peter, W Chan, M Freilich, N Htun, R Prakash, L Selkrig, Austin Hospital: DJ Clark, O Farouque, M Yudi, M Horrigan, J Johns, L Oliver, J Brennan, R Chan, G Proimos, T Dortimer, B Chan, V Nadurata, R Huq, D Fernando, L Brown, A AlFiadh, J Ramchand, J Yeoh, S Picardo. Ballarat Base Hospital: E Oqueli, A Sharma, N Ryan, C Barry. Box Hill Hospital: M Freeman, J Cooke, L Roberts, J Chandrasekhar, A Teh, M Rowe, G Proimos, Y Cheong, C Goods, D Fernando, K Soon, D Natarajan, L Marceddo. Geelong Hospital: C Hiew, M Sebastian, T Yip, A Hutchinson, C Jaworski, M Mok, B McDonald, N Herbert, R Pavelitch. Royal Melbourne Hospital: AE Ajani, R Warren, D Eccleston, J Lefkovits, R Iyer, R Gurvitch, W Wilson, M Brooks, LP Dawson.
Funding Information:
The Melbourne Interventional Group acknowledges funding from Abbott Vascular, Astra-Zeneca, BMS and Pfizer. These companies do not have access to data and do not have the right to review manuscripts or abstracts before publication.
Funding Information:
Professor Stephen Duffy's work is supported by a NHMRC grant. Professor Reid is supported by a NHMRC Senior Research Fellowship (reference no. 1045862). A/Prof Stub is supported by a NHF Future Leader Fellowship (reference no. 101908), and a Viertel Foundation Clinical Investigator award.
Publisher Copyright:
© 2020
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Background: In cardiogenic shock with severe left main coronary artery stenosis (LM), limited information exists on short and longer-term outcomes. We sought to determine the outcomes of unprotected LM PCI in cardiogenic shock. Methods: Excluding patients with previous CABG, consecutive patients undergoing PCI in cardiogenic shock from the Melbourne Intervention Group registry between 2005 and 2013 were analysed. Those post LM PCI were compared to those post non-LM PCI. Patient and procedural data were collected with 30-day and 12-month follow-up. Australian National Death Index linkage was performed for long-term mortality analysis. Results: After excluding previous CABG, 18,069 procedures were performed during 1st January 2005 to 30th November 2013, 601 procedures in the setting of cardiogenic shock. Of these, 45 were performed to an isolated LM and 556 to a non-LM. Those with LM PCI were older and more likely to have a baseline left ventricular ejection fraction (LVEF) of <45%. The in-hospital, 30-day, 12-month and long-term mortality to 9 years in cardiogenic shock after LM PCI was 64.4%, 66.7%, 73.3% and 80.0% compared to 36.5%, 36.9%, 40.5% and 46.0%, after non-LM PCI (p < 0.001). On multivariate analysis, LM PCI was a significant independent predictor of long-term mortality (HR1.59, 95%CI 1.00–2.53, p = 0.048). Landmark analysis of survivors to discharge found the long-term mortality of LM PCI approaches 60% compared to 27% for those with non-LM PCI (p = 0.003). Conclusion: Long-term outcomes after PCI to LM in cardiogenic shock are poor, with much of the excess in mortality occurring early. However, reasonable long-term survival was found beyond the initial high-risk period.
AB - Background: In cardiogenic shock with severe left main coronary artery stenosis (LM), limited information exists on short and longer-term outcomes. We sought to determine the outcomes of unprotected LM PCI in cardiogenic shock. Methods: Excluding patients with previous CABG, consecutive patients undergoing PCI in cardiogenic shock from the Melbourne Intervention Group registry between 2005 and 2013 were analysed. Those post LM PCI were compared to those post non-LM PCI. Patient and procedural data were collected with 30-day and 12-month follow-up. Australian National Death Index linkage was performed for long-term mortality analysis. Results: After excluding previous CABG, 18,069 procedures were performed during 1st January 2005 to 30th November 2013, 601 procedures in the setting of cardiogenic shock. Of these, 45 were performed to an isolated LM and 556 to a non-LM. Those with LM PCI were older and more likely to have a baseline left ventricular ejection fraction (LVEF) of <45%. The in-hospital, 30-day, 12-month and long-term mortality to 9 years in cardiogenic shock after LM PCI was 64.4%, 66.7%, 73.3% and 80.0% compared to 36.5%, 36.9%, 40.5% and 46.0%, after non-LM PCI (p < 0.001). On multivariate analysis, LM PCI was a significant independent predictor of long-term mortality (HR1.59, 95%CI 1.00–2.53, p = 0.048). Landmark analysis of survivors to discharge found the long-term mortality of LM PCI approaches 60% compared to 27% for those with non-LM PCI (p = 0.003). Conclusion: Long-term outcomes after PCI to LM in cardiogenic shock are poor, with much of the excess in mortality occurring early. However, reasonable long-term survival was found beyond the initial high-risk period.
KW - Acute myocardial infarction
KW - Cardiogenic shock
KW - Left main coronary artery
KW - Percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=85081891032&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2020.03.005
DO - 10.1016/j.ijcard.2020.03.005
M3 - Article
C2 - 32192748
AN - SCOPUS:85081891032
SN - 0167-5273
VL - 308
SP - 20
EP - 25
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -